A venture that includes global office developer Tishman Speyer is ramping up an already $3 billion bet on the recovery of biotech real estate with the launch of a fund meant to take advantage of lower prices stemming from a glut of space and slow demand.
Tishman Speyer venture ramps up wager on biotech real estate recovery
Seeking discounted deals, Breakthrough Properties’ latest fund follows $3 billion bet
By Lou Hirsh
CoStar NewsNovember 19, 2025 | 9:48 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- Breakthrough Properties LLC
Real Estate
- Tishman Speyer
Real Estate